[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Active Pharmaceutical Ingredients (API) Market Professional Survey Report 2016

September 2016 | 112 pages | ID: G2362D643DFEN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Production, means the output of Active Pharmaceutical Ingredients (API)

Revenue, means the sales value of Active Pharmaceutical Ingredients (API)

This report studies Active Pharmaceutical Ingredients (API) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
  • TEVA
  • DSM
  • Novartis
  • Roche
  • Johnson & Johnson
  • Dr. Reddy’s Laboratories
  • Pfizer
  • Bayer
  • BASF
  • Cambrex
By types, the market can be split into
  • Natural (Biochemistry/Phytochemistry medicine)
  • Synthetic (Inorganic/organic synthetic medicine)
  • Type III
By Application, the market can be split into
  • Application 1
  • Application 2
  • Application 3
By Regions, this report covers (we can add the regions/countries as you want)
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Global Active Pharmaceutical Ingredients (API) Market Professional Survey Report 2016

1 INDUSTRY OVERVIEW OF ACTIVE PHARMACEUTICAL INGREDIENTS (API)

1.1 Definition and Specifications of Active Pharmaceutical Ingredients (API)
  1.1.1 Definition of Active Pharmaceutical Ingredients (API)
  1.1.2 Specifications of Active Pharmaceutical Ingredients (API)
1.2 Classification of Active Pharmaceutical Ingredients (API)
  1.2.1 Natural (Biochemistry/Phytochemistry medicine)
  1.2.2 Synthetic (Inorganic/organic synthetic medicine)
  1.2.3 Type III
1.3 Applications of Active Pharmaceutical Ingredients (API)
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 Europe
  1.4.3 China
  1.4.4 Japan
  1.4.5 Southeast Asia
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS (API)

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredients (API)
2.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
2.4 Industry Chain Structure of Active Pharmaceutical Ingredients (API)

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS (API)

3.1 Capacity and Commercial Production Date of Global Active Pharmaceutical Ingredients (API) Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Active Pharmaceutical Ingredients (API) Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Active Pharmaceutical Ingredients (API) Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Active Pharmaceutical Ingredients (API) Major Manufacturers in 2015

4 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2011-2016E Global Active Pharmaceutical Ingredients (API) Capacity and Growth Rate Analysis
  4.2.2 2015 Active Pharmaceutical Ingredients (API) Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2016E Global Active Pharmaceutical Ingredients (API) Sales and Growth Rate Analysis
  4.3.2 2015 Active Pharmaceutical Ingredients (API) Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2016E Global Active Pharmaceutical Ingredients (API) Sales Price
  4.4.2 2015 Active Pharmaceutical Ingredients (API) Sales Price Analysis (Company Segment)

5 ACTIVE PHARMACEUTICAL INGREDIENTS (API) REGIONAL MARKET ANALYSIS

5.1 North America Active Pharmaceutical Ingredients (API) Market Analysis
  5.1.1 North America Active Pharmaceutical Ingredients (API) Market Overview
  5.1.2 North America 2011-2016E Active Pharmaceutical Ingredients (API) Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2011-2016E Active Pharmaceutical Ingredients (API) Sales Price Analysis
  5.1.4 North America 2015 Active Pharmaceutical Ingredients (API) Market Share Analysis
5.2 Europe Active Pharmaceutical Ingredients (API) Market Analysis
  5.2.1 Europe Active Pharmaceutical Ingredients (API) Market Overview
  5.2.2 Europe 2011-2016E Active Pharmaceutical Ingredients (API) Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Europe 2011-2016E Active Pharmaceutical Ingredients (API) Sales Price Analysis
  5.2.4 Europe 2015 Active Pharmaceutical Ingredients (API) Market Share Analysis
5.3 China Active Pharmaceutical Ingredients (API) Market Analysis
  5.3.1 China Active Pharmaceutical Ingredients (API) Market Overview
  5.3.2 China 2011-2016E Active Pharmaceutical Ingredients (API) Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 China 2011-2016E Active Pharmaceutical Ingredients (API) Sales Price Analysis
  5.3.4 China 2015 Active Pharmaceutical Ingredients (API) Market Share Analysis
5.4 Japan Active Pharmaceutical Ingredients (API) Market Analysis
  5.4.1 Japan Active Pharmaceutical Ingredients (API) Market Overview
  5.4.2 Japan 2011-2016E Active Pharmaceutical Ingredients (API) Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Japan 2011-2016E Active Pharmaceutical Ingredients (API) Sales Price Analysis
  5.4.4 Japan 2015 Active Pharmaceutical Ingredients (API) Market Share Analysis
5.5 Southeast Asia Active Pharmaceutical Ingredients (API) Market Analysis
  5.5.1 Southeast Asia Active Pharmaceutical Ingredients (API) Market Overview
  5.5.2 Southeast Asia 2011-2016E Active Pharmaceutical Ingredients (API) Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Southeast Asia 2011-2016E Active Pharmaceutical Ingredients (API) Sales Price Analysis
  5.5.4 Southeast Asia 2015 Active Pharmaceutical Ingredients (API) Market Share Analysis
5.6 India Active Pharmaceutical Ingredients (API) Market Analysis
  5.6.1 India Active Pharmaceutical Ingredients (API) Market Overview
  5.6.2 India 2011-2016E Active Pharmaceutical Ingredients (API) Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2011-2016E Active Pharmaceutical Ingredients (API) Sales Price Analysis
  5.6.4 India 2015 Active Pharmaceutical Ingredients (API) Market Share Analysis

6 GLOBAL 2011-2016E ACTIVE PHARMACEUTICAL INGREDIENTS (API) SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Active Pharmaceutical Ingredients (API) Sales by Type
6.2 Different Types of Active Pharmaceutical Ingredients (API) Product Interview Price Analysis
6.3 Different Types of Active Pharmaceutical Ingredients (API) Product Driving Factors Analysis
  6.3.1 Natural (Biochemistry/Phytochemistry medicine) of Active Pharmaceutical Ingredients (API) Growth Driving Factor Analysis
  6.3.2 Synthetic (Inorganic/organic synthetic medicine) of Active Pharmaceutical Ingredients (API) Growth Driving Factor Analysis
  6.3.3 Type III Active Pharmaceutical Ingredients (API) Growth Driving Factor Analysis

7 GLOBAL 2011-2016E ACTIVE PHARMACEUTICAL INGREDIENTS (API) SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Active Pharmaceutical Ingredients (API) Consumption by Application
7.2 Different Application of Active Pharmaceutical Ingredients (API) Product Interview Price Analysis
7.3 Different Application of Active Pharmaceutical Ingredients (API) Product Driving Factors Analysis
  7.3.1 Application 1 Active Pharmaceutical Ingredients (API) Growth Driving Factor Analysis
  7.3.2 Application 2 Active Pharmaceutical Ingredients (API) Growth Driving Factor Analysis
  7.3.3 Application 3 Active Pharmaceutical Ingredients (API) Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS (API)

8.1 TEVA
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Type I
    8.1.2.2 Type II
    8.1.2.3 Type III
  8.1.3 TEVA 2015 Active Pharmaceutical Ingredients (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 TEVA 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution Analysis
8.2 DSM
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Type I
    8.2.2.2 Type II
    8.2.2.3 Type III
  8.2.3 DSM 2015 Active Pharmaceutical Ingredients (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 DSM 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution Analysis
8.3 Novartis
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Type I
    8.3.2.2 Type II
    8.3.2.3 Type III
  8.3.3 Novartis 2015 Active Pharmaceutical Ingredients (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Novartis 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution Analysis
8.4 Roche
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Type I
    8.4.2.2 Type II
    8.4.2.3 Type III
  8.4.3 Roche 2015 Active Pharmaceutical Ingredients (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Roche 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution Analysis
8.5 Johnson & Johnson
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Type I
    8.5.2.2 Type II
    8.5.2.3 Type III
  8.5.3 Johnson & Johnson 2015 Active Pharmaceutical Ingredients (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Johnson & Johnson 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution Analysis
8.6 Dr. Reddy’s Laboratories
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Type I
    8.6.2.2 Type II
    8.6.2.3 Type III
  8.6.3 Dr. Reddy’s Laboratories 2015 Active Pharmaceutical Ingredients (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Dr. Reddy’s Laboratories 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution Analysis
8.7 Pfizer
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Type I
    8.7.2.2 Type II
    8.7.2.3 Type III
  8.7.3 Pfizer 2015 Active Pharmaceutical Ingredients (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Pfizer 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution Analysis
8.8 Bayer
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Type I
    8.8.2.2 Type II
    8.8.2.3 Type III
  8.8.3 Bayer 2015 Active Pharmaceutical Ingredients (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Bayer 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution Analysis
8.9 BASF
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Type I
    8.9.2.2 Type II
    8.9.2.3 Type III
  8.9.3 BASF 2015 Active Pharmaceutical Ingredients (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 BASF 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution Analysis
8.10 Cambrex
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Type I
    8.10.2.2 Type II
    8.10.2.3 Type III
  8.10.3 Cambrex 2015 Active Pharmaceutical Ingredients (API) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Cambrex 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET

9.1 Global Active Pharmaceutical Ingredients (API) Market Trend Analysis
  9.1.1 Global 2016-2021 Active Pharmaceutical Ingredients (API) Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Active Pharmaceutical Ingredients (API) Sales Price Forecast
9.2 Active Pharmaceutical Ingredients (API) Regional Market Trend
  9.2.1 North America 2016-2021 Active Pharmaceutical Ingredients (API) Consumption Forecast
  9.2.2 Europe 2016-2021 Active Pharmaceutical Ingredients (API) Consumption Forecast
  9.2.3 China 2016-2021 Active Pharmaceutical Ingredients (API) Consumption Forecast
  9.2.4 Japan 2016-2021 Active Pharmaceutical Ingredients (API) Consumption Forecast
  9.2.5 Southeast Asia 2016-2021 Active Pharmaceutical Ingredients (API) Consumption Forecast
  9.2.6 India 2016-2021 Active Pharmaceutical Ingredients (API) Consumption Forecast
9.3 Active Pharmaceutical Ingredients (API) Market Trend (Product Type)
9.4 Active Pharmaceutical Ingredients (API) Market Trend (Application)

10 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKETING TYPE ANALYSIS

10.1 Active Pharmaceutical Ingredients (API) Regional Marketing Type Analysis
10.2 Active Pharmaceutical Ingredients (API) International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Active Pharmaceutical Ingredients (API) by Regions
10.4 Active Pharmaceutical Ingredients (API) Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ACTIVE PHARMACEUTICAL INGREDIENTS (API)

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET PROFESSIONAL SURVEY REPORT 2016

Author List
Table Part of Interviewees Record List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Active Pharmaceutical Ingredients (API)
Table Product Specifications of Active Pharmaceutical Ingredients (API)
Table Classification of Active Pharmaceutical Ingredients (API)
Figure Global Production Market Share of Active Pharmaceutical Ingredients (API) by Type in 2015
Figure Natural (Biochemistry/Phytochemistry medicine) Picture
Table Major Manufacturers of Natural (Biochemistry/Phytochemistry medicine)
Figure Synthetic (Inorganic/organic synthetic medicine) Picture
Table Major Manufacturers of Synthetic (Inorganic/organic synthetic medicine)
Table Applications of Active Pharmaceutical Ingredients (API)
Figure Global Consumption Volume Market Share of Active Pharmaceutical Ingredients (API) by Application in 2015
Figure Market Share of Active Pharmaceutical Ingredients (API) by Regions
Figure North America Active Pharmaceutical Ingredients (API) Market Size (2011-2021)
Figure Europe Active Pharmaceutical Ingredients (API) Market Size (2011-2021)
Figure China Active Pharmaceutical Ingredients (API) Market Size (2011-2021)
Figure Japan Active Pharmaceutical Ingredients (API) Market Size (2011-2021)
Figure Southeast Asia Active Pharmaceutical Ingredients (API) Market Size (2011-2021)
Figure India Active Pharmaceutical Ingredients (API) Market Size (2011-2021)
Table Active Pharmaceutical Ingredients (API) Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredients (API) in 2015
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
Figure Industry Chain Structure of Active Pharmaceutical Ingredients (API)
Table Capacity (K MT) and Commercial Production Date of Global Active Pharmaceutical Ingredients (API) Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Active Pharmaceutical Ingredients (API) Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Active Pharmaceutical Ingredients (API) Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Active Pharmaceutical Ingredients (API) Major Manufacturers in 2015
Table Global Capacity (K MT), Sales (K MT), Price (USD/MT), Cost (USD/MT), Sales Revenue (M USD) and Gross Margin of Active Pharmaceutical Ingredients (API) 2011-2016
Figure Global 2011-2016E Active Pharmaceutical Ingredients (API) Market Size (Volume) and Growth Rate
Figure Global 2011-2016E Active Pharmaceutical Ingredients (API) Market Size (Value) and Growth Rate
Table 2011-2016E Global Active Pharmaceutical Ingredients (API) Capacity and Growth Rate
Table 2015 Global Active Pharmaceutical Ingredients (API) Capacity List (Company Segment)
Table 2011-2016E Global Active Pharmaceutical Ingredients (API) Sales and Growth Rate
Table 2015 Global Active Pharmaceutical Ingredients (API) Sales List (Company Segment)
Table 2011-2016E Global Active Pharmaceutical Ingredients (API) Sales Price
Table 2015 Global Active Pharmaceutical Ingredients (API) Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2011-2016 (K MT)
Figure North America 2011-2016E Active Pharmaceutical Ingredients (API) Sales Price (USD/MT)
Figure North America 2015 Active Pharmaceutical Ingredients (API) Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2011-2016 (K MT)
Figure Europe 2011-2016E Active Pharmaceutical Ingredients (API) Sales Price (USD/MT)
Figure Europe 2015 Active Pharmaceutical Ingredients (API) Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2011-2016 (K MT)
Figure China 2011-2016E Active Pharmaceutical Ingredients (API) Sales Price (USD/MT)
Figure China 2015 Active Pharmaceutical Ingredients (API) Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2011-2016 (K MT)
Figure Japan 2011-2016E Active Pharmaceutical Ingredients (API) Sales Price (USD/MT)
Figure Japan 2015 Active Pharmaceutical Ingredients (API) Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2011-2016 (K MT)
Figure Southeast Asia 2011-2016E Active Pharmaceutical Ingredients (API) Sales Price (USD/MT)
Figure Southeast Asia 2015 Active Pharmaceutical Ingredients (API) Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Active Pharmaceutical Ingredients (API) 2011-2016 (K MT)
Figure India 2011-2016E Active Pharmaceutical Ingredients (API) Sales Price (USD/MT)
Figure India 2015 Active Pharmaceutical Ingredients (API) Sales Market Share
Table Global 2011-2016E Active Pharmaceutical Ingredients (API) Sales by Type
Table Different Types Active Pharmaceutical Ingredients (API) Product Interview Price
Table Global 2011-2016E Active Pharmaceutical Ingredients (API) Sales by Application
Table Different Application Active Pharmaceutical Ingredients (API) Product Interview Price
Table TEVA Information List
Table Type I Active Pharmaceutical Ingredients (API) Overview
Table Type II Active Pharmaceutical Ingredients (API) Overview
Table Type III Active Pharmaceutical Ingredients (API) Overview
Table 2015 TEVA Active Pharmaceutical Ingredients (API) Revenue, Sales, Ex-factory Price
Figure 2015 TEVA 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution
Table DSM Information List
Table Type I Active Pharmaceutical Ingredients (API) Overview
Table Type II Active Pharmaceutical Ingredients (API) Overview
Table Type III Active Pharmaceutical Ingredients (API) Overview
Table 2015 DSM Active Pharmaceutical Ingredients (API) Revenue, Sales, Ex-factory Price
Figure 2015 DSM 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution
Table Novartis Information List
Table Type I Active Pharmaceutical Ingredients (API) Overview
Table Type II Active Pharmaceutical Ingredients (API) Overview
Table Type III Active Pharmaceutical Ingredients (API) Overview
Table 2015 Novartis Active Pharmaceutical Ingredients (API) Revenue, Sales, Ex-factory Price
Figure 2015 Novartis 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution
Table Roche Information List
Table Type I Active Pharmaceutical Ingredients (API) Overview
Table Type II Active Pharmaceutical Ingredients (API) Overview
Table Type III Active Pharmaceutical Ingredients (API) Overview
Table 2015 Roche Active Pharmaceutical Ingredients (API) Revenue, Sales, Ex-factory Price
Figure 2015 Roche 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution
Table Johnson & Johnson Information List
Table Type I Active Pharmaceutical Ingredients (API) Overview
Table Type II Active Pharmaceutical Ingredients (API) Overview
Table Type III Active Pharmaceutical Ingredients (API) Overview
Table 2015 Johnson & Johnson Active Pharmaceutical Ingredients (API) Revenue, Sales, Ex-factory Price
Figure 2015 Johnson & Johnson 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution
Table Dr. Reddy’s Laboratories Information List
Table Type I Active Pharmaceutical Ingredients (API) Overview
Table Type II Active Pharmaceutical Ingredients (API) Overview
Table Type III Active Pharmaceutical Ingredients (API) Overview
Table 2015 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Revenue, Sales, Ex-factory Price
Figure 2015 Dr. Reddy’s Laboratories 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution
Table Pfizer Information List
Table Type I Active Pharmaceutical Ingredients (API) Overview
Table Type II Active Pharmaceutical Ingredients (API) Overview
Table Type III Active Pharmaceutical Ingredients (API) Overview
Table 2015 Pfizer Active Pharmaceutical Ingredients (API) Revenue, Sales, Ex-factory Price
Figure 2015 Pfizer 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution
Table Bayer Information List
Table Type I Active Pharmaceutical Ingredients (API) Overview
Table Type II Active Pharmaceutical Ingredients (API) Overview
Table Type III Active Pharmaceutical Ingredients (API) Overview
Table 2015 Bayer Active Pharmaceutical Ingredients (API) Revenue, Sales, Ex-factory Price
Figure 2015 Bayer 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution
Table BASF Information List
Table Type I Active Pharmaceutical Ingredients (API) Overview
Table Type II Active Pharmaceutical Ingredients (API) Overview
Table Type III Active Pharmaceutical Ingredients (API) Overview
Table 2015 BASF Active Pharmaceutical Ingredients (API) Revenue, Sales, Ex-factory Price
Figure 2015 BASF 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution
Table Cambrex Information List
Table Type I Active Pharmaceutical Ingredients (API) Overview
Table Type II Active Pharmaceutical Ingredients (API) Overview
Table Type III Active Pharmaceutical Ingredients (API) Overview
Table 2015 Cambrex Active Pharmaceutical Ingredients (API) Revenue, Sales, Ex-factory Price
Figure 2015 Cambrex 2015 Active Pharmaceutical Ingredients (API) Business Region Distribution
Figure Global 2016-2021 Active Pharmaceutical Ingredients (API) Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Active Pharmaceutical Ingredients (API) Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Active Pharmaceutical Ingredients (API) Sales Price (USD/MT) Forecast
Figure North America 2016-2021 Active Pharmaceutical Ingredients (API) Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Active Pharmaceutical Ingredients (API) Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Active Pharmaceutical Ingredients (API) Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Active Pharmaceutical Ingredients (API) Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Active Pharmaceutical Ingredients (API) Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Active Pharmaceutical Ingredients (API) Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (K MT) of Active Pharmaceutical Ingredients (API) by Types 2016-2021
Table Global Consumption Volume (K MT) of Active Pharmaceutical Ingredients (API) by Applications 2016-2021
Table Traders or Distributors with Contact Information of Active Pharmaceutical Ingredients (API) by Regions
Table Part of Interviewees Record List


More Publications